USA Today: “Plant foods to the rescue”

Scientists who study nutrition paint a very different picture.

A growing body of research shows that, once inside the body, fruits and vegetables spring into the role of superheroes, fighting cancer and other diseases in at least eight simultaneous ways. And, like the Superfriends, they seem to work better as a team. Some phytochemicals, or plant chemicals, knock out carcinogens and fight inflammation. Some regulate how quickly cells reproduce and spur old, damaged cells to self-destruct. Other plant chemicals perform “routine maintenance” on DNA, says Jeff Prince, vice president for education at the Washington-based American Institute for Cancer Research.

Doctors caution that recent research indicates that fruits and vegetables may not provide as much protection against cancer as once believed. In the past five years, studies have shown that weight control may be more crucial, says Walt Willett, chairman of the nutrition department at the Harvard School of Public Health.

Yet most experts agree that the body needs a variety of these phytochemicals – there are more than 25,000 of them – to stay in top form. That’s why so many nutritionists no longer stress individual “power foods,” Prince says, but instead promote a “plant-based” diet of fruits, vegetables, whole grains, beans and nuts. Preliminary research indicates these foods bring out the best in each other and magnify their protective effects.

At the cancer institute’s annual scientific conference in July, researchers from the University of Illinois-Urbana described their research feeding tomatoes and broccoli to lab rats that had prostate cancer. The tumors of rats that were fed both vegetables shrank far more than those of animals who ate either food alone. Researchers stressed, though, that people do not necessarily react the same way as animals and that many larger studies need to be done to confirm these results.

“The take-home message is not that experts recommend tomatoes and broccoli,” Prince said at the conference. “We’re not going to find a single source that fights disease. What’s important is the interaction of thousands of plant chemicals.” Humans evolved to depend on a rich diet of 800 plant foods, says David Heber, director of the University of California-Los Angeles Center for Human Nutrition. Today, he says, most people eat three, and those are often french fries, ketchup and iceberg lettuce.

Yet some potentially potent plant foods, experts say, are exotic varieties that Americans rarely sample: herbs such as ginseng; spices such as turmeric, used in Indian cooking; and Reishi and Maitake mushrooms from Japan. Heber suggests that people select their five to nine recommended daily servings of fruits and vegetables from seven color groups, such as purple grapes or yellow squash, whose colors are produced by disease-fighting chemicals called carotenoids.

Scientists have identified only a handful of the thousands of potentially beneficial plant chemicals, says Daniel Nixon, author of The Prostate Health Program and president of the Institute for Cancer Prevention in New York. People who would rather pop dietary supplements instead of eating the real thing may miss out on proven health promoters such as fiber, as well as compounds that scientists have yet to discover, Nixon says. Last week, the American Heart Association published an advisory finding that antioxidant supplements do not prevent heart disease. In some studies, supplements with beta carotene – the chemical that colors carrots orange – increased the risk of cancer.

Plants vs. disease

Plant foods, however, may help prevent a number of diseases, says Rachel Brandeis of the American Dietetic Association. Antioxidants found in vegetables neutralize dangerous molecules called “free radicals,” which are produced by smoking and radiation, as well as everyday activities of the body. Left to themselves, free radicals attack healthy cells and may lead to plaques in the arteries and even Alzheimer’s. They also can damage DNA in ways that lead to cancer. As plants evolved, they developed antioxidants to fight free radicals, Heber says. Humans grew to depend on fruits, vegetables and nuts to provide these vital defenses. That may explain why, without a rich plant diet, people are more vulnerable to disease. Diets rich in plant compounds, on the other hand, may prevent a variety of ailments.

At a meeting of the Alzheimer’s Association last month, for example, researchers presented the results of a six-year study of 3,000 senior citizens. In the study, people who consumed lots of vitamin C and carotenoids, both through food and supplements, scored higher on reasoning tests. Carotenoids are found in squash, strawberries and other fruits. According to another study presented at the meeting, vegetables such as spinach and broccoli – which contain vitamin C and carotenoids, as well as the vitamin folic acid – were found to slow cognitive decline.

Other things that appear to lower the risk of Alzheimer’s include vitamin E, found in wheat germ, and fatty fish, such as salmon and mackerel, which are rich in omega-3 fatty acids, according to the Alzheimer’s Association. Scientists say they still have many questions about antioxidants: Can they fight cancer at any stage of the disease or at any age? Or do people benefit only if they consume these foods from infancy? Under which circumstances might antioxidants promote disease, rather than healing?

Scientists have identified at least a handful of the ways that plant foods appear to fight disease, says Cheryl Rock, a professor of nutrition at the University of California-San Diego Cancer Center. * By mopping up free radicals, antioxidants such as the beta carotene in sweet potatoes or the vitamin E in almonds prevent cell damage. Another class of chemicals called flavonoids have been shown to activate the body’s natural DNA repair system.

* Fruits and vegetables often are high in potassium, which can help control blood pressure.

* Antioxidants may interrupt a process leading to inflammation, which appears to play a role in cardiovascular disease and cancer. Vitamin B6, found in bananas, and folic acid, found in broccoli and leafy greens, both lower levels of homocysteine, which has been linked to hardening of the arteries, heart attacks, strokes and dementia.

* Chemicals such as beta carotene also help regulate the natural cycle of cell birth and death, telling cells when to divide, differentiate into new types or recycle themselves. Keeping this process under tight control can prevent cancer, Rock says.

* Phytochemicals in foods such as Brussels sprouts, red cabbage and kale may help prevent cancer by activating enzymes that break down carcinogens.

Antioxidants vs. angiogenesis

* Emerging research suggests that antioxidants may shut down a process called angiogenesis, by which tumors recruit blood supplies that help them grow and spread, says William Li, president of the Angiogenesis Foundation. Scientists are investigating links between angiogenesis and compounds found in foods such as licorice, blueberries and garlic, Li says.

Researchers who studied tumors in mice were able to cut back the number of new blood vessels by 70% simply by replacing their water with green tea, Li says. Scientists have not proved this link in humans.

* Plant foods such as whole-grain cereals and oats are loaded with fiber. In a study of 40,000 male health professionals, high-fiber diets reduced the risk of coronary heart disease by 40%. Diets filled with cereal fiber also may help prevent diabetes and a painful intestinal inflammation called diverticular disease. “Mother Nature is cleverer than all of us and has laced many of our favorite foods with things that can be helpful,” Li says. “Ancient cultures have long recognized that your diet can be healing, and
scientists are only now beginning to understand why.” Digest the benefits of this basket of foods

Many nutritionists today stress the importance of healthy dietary patterns – ones filled with vegetables, fruits, whole grains, beans, nuts and lean proteins – combined with regular exercise and weight control. Though no one food is a “magic bullet,” some experts encourage people to include foods such as these in their diets.

Digest the benefits of this basket of foods

Many nutritionists today stress the importance of healthy dietary patterns ones filled with vegetables, fruits, whole grains, beans, nuts and lean proteins – combined with regular exercise and weight control. Though no one food is a “magic bullet,” some experts encourage people to include foods such as these in their diets. Tomatoes The carotenoid lycopene. Eating several servings a week may reduce the risk of prostate cancer up to 35% and also may reduce the risk of heart attack and stroke. To get the most lycopene, cook tomatoes with a little “healthful” fat, such as olive oil.

Whole-grain breads and cereals Fiber and antioxidants. May lower the risk of heart disease by 40%. May also help prevent diabetes. Read labels to make sure that the first ingredient in the bread says whole wheat, not just wheat or “stone-ground wheat.” Salmon, mackeral, sardines Omega-3 fatty acids. Reduces risk of heart disease, diabetes and possibly Alzheimer’s and cancer. Reduces inflammation, which may help prevent or relieve symptoms of arthritis. Contains vitamin D, which builds strong bones and may protect against colon cancer. Cooked, to kill microorganisms and parasites. Broiled, to eliminate contaminants found in freshwater fish. For canned fish, serve with the soft, mashed, calcium-rich bones.

Spinach and other leafy greens Folic acid. This may reduce risk of birth defects, heart attack, Alzheimer’s, depression and inflammation. Folic acid also reduces the risk of fractures. Potassium lowers blood pressure and the danger of strokes. The carotenoids lutein and zeaxanthin may help fight age-related eye disease. Antioxidants called flavones may reduce breast cancer risk.  Fresh or lightly steamed to preserve vitamin C; with nuts, olive oil or avocados, whose fat helps to increase absorption of antioxidants.

Blueberries or other berries Antioxidants such as vitamin C. These may reduce risk of heart disease, cancer, mental decline and other diseases of aging. May help prevent urinary-tract infections by inhibiting bacteria.  Fresh, raw or lightly cooked. Wash them just before serving to avoid mold and bruising. Canning blueberries removes half of the vitamin C. Sweet potatoes Carotenoids, which may help reduce the risk of Alzheimer’s. Beta carotene also may lower the risk of cancers of the larynx, esophagus and lungs. Baked or boiled.

 

NEW VERSION OF TEST FOR CANCER-CAUSING AGENTS NEEDS NO ANIMALS

A new version of a popular test for cancer-causing agents is cheaper, more sensitive and, best of all, animal-free, thanks to a U of G researcher. Prof. David Josephy, Chemistry and Biochemistry, has developed a way of testing substances for cancer-causing potential without using animal tissue. Instead, his version of the Ames test involves gene splicing.

“Nobody has figured a way around using animals until now,” says Josephy. “We hope that no more animals will have to die for the sake of the Ames test.” Two decades ago, the Ames test (named after inventor Bruce Ames, a bacterial geneticist from the University of California at Berkeley) was heralded as a breakthrough in cancer research. Ames’s goal was to eliminate the use of animals in tests for cancer-causing or “mutagenic” agents.

In his efforts to put an end to animal use, Ames came up with a way to use animal tissue for his tests, rather than the whole animal. In animals, cancer-causing agents are inactive until they’re chemically changed or “metabolized” by certain enzymes. When they’re changed, they become dangerous because they’re converted into different forms of chemicals.

Ames chose rodent liver extracts for his test because the liver contains more metabolic enzymes than other organs do. In a test tube, he combined liver cells and bacteria. He used bacteria because they’re so small that billions of cells can be affected by the mutagen in one test, making results easier to observe. When a potential cancer-causing agent is introduced into the test tube, it’s metabolized by the enzymes in the liver and causes DNA damage or mutations to the bacterial cells. DNA damage mutates cells, which results in cancer in animals.

The test has enabled researchers to identify carcinogens such as the charring on burnt food and a chemical used to fireproof children’s pyjamas, which was banned after the discovery was made. The Ames test used only a portion of a rodent’s liver. That meant it reduced the use of animals needed to detect suspected mutagens because one liver provided enough material for hundreds of tests. With the Ames test, mutagen-detection laboratories need to use only a few dozen rodent livers each year instead of the thousands of animals that lifetime feeding tests would require.

Now Josephy has taken that a step further. He has completely eliminated the need for animals to be involved. In the last few years, researchers have identified the gene — called P4501A2 — that makes the enzyme needed to metabolize carcinogens so they become mutagenic. Different enzymes metabolize different carcinogens; the enzyme P4501A2 metabolizes one class of compounds called aromatic amines, the carcinogens in charred material.

Josephy spliced the P4501A2 gene into the bacterial cell responsible for producing the metabolizing enzyme that identifies it as a mutagen. By splicing the gene into the bacteria, he’s made it possible for the bacteria to produce the required enzyme, so that no rat liver is needed. As a result, when potential mutagenic chemicals are introduced, the bacteria are a complete mutagen-detecting package  in themselves.

Josephy has installed a clone of the human P4501A2 gene into the bacteria to make the test even more representative of human metabolism. The cloned human genes come from Peter Guengerich, a collaborator at the Vanderbilt University School of Medicine in Nashville. “It means we can do a much more sophisticated mutagen analysis than we could in the past,” says Josephy. “We’re fulfilling Ames’s goal.” This work is sponsored by the National Cancer Institute of Canada and the Natural Sciences and Engineering Research Council.

 

US-CA, An Associate Scientist in Cell Biology, Cancer Research

COMPANY
Well-equipped U.S. research headquarters of international drug discovery company. Attractive campus. Excellent resources. High caliber of science. Company is committed to cutting edge research. Provides cutting-edge tools and support. Highly collaborative environment.

DESCRIPTION
Cell biology associate scientist for a cancer research group heavily focused on breast cancer. Apply 3 to 5 years of relevant experience ideally acquired within an industrial biotech environment.

RESPONSIBILITIES
Within a cell biology department, support cancer research genomics program focused on breast cancer. Apply knowledge in cell biology, cell based assays, cell-cell and cell-matrix signaling mechanisms, and antibody experience. Develop, optimize and perform cell-based assays to evaluate novel-gene therapeutic candidates. Validate novel protein drug targets utilizing strategies such as neutralizing antibodies and anti-sense oligonucleotide-based gene knock-outs. Another validation method used will be transfections of wild-type and dominant negative protein.

LOCATION
San Francisco Bay Area.
QUALIFICATIONS
BS or MS in cell biology with 3 to 5 years of pertinent experience, ideally within an industrial biotech setting. Broad knowledge of cell biology. Cell based assay experience (ex: proliferation, apoptosis, migrations and/or invasion assays). Experience working with cancer cell lines. The ability to manipulate a cell is important. Two crucial areas of technical knowledge are: 1.) Mammalian cell transfection and 2.) Delivering antisense oligonucleotides. Ideally we are seeking experience in the culture and transfection of primary and established human cell lines. Strong interpersonal and problem solving skills also important..

DESIRED (Not Mandatory)
Possible growth factor experience. Extracellular matrix interaction. Familiarity with: DNA expression vectors. Antisense olignucleotides. Immuno-cytochemistry and antibody characterization. Molecular biology techniques: such as cDNA cloning, DNA and RNA isolation. Northern and Western blot analysis.

COMPENSATION
Competitive salary and benefits.

 

Lycopene for Prostate Cancer – Research Summary

BACKGROUND: Harvard researchers reported in a 2002 article in the Journal of the National Cancer Institute that eating tomato products on a regular basis is associated with a reduced risk of prostate cancer. The research included more than 47,000 participants. Researchers then continued to follow the men for several more years to learn more about the specific foods that seem to protect men from prostate cancer. That research was published this year — also in the Journal of the National Cancer Institute. The study reports men who ate tomato sauce at least twice a week were about 20-percent less likely to develop prostate cancer when compared to men who rarely ate it.
CURRENT RESEARCH: Moffitt Cancer Center in Tampa, Florida is conducting a study to look at the mechanism by which lycopene actually stops the promotion of prostate cancer cells. For the study, men with cancer who are having their prostate surgically removed are participating. Generally, the men wait six weeks after diagnosis before they have the surgery. During the six-week period, each participant is given one of three doses of lycopene or a placebo. Researchers will then compare the cancer cells from the pre-surgical biopsy and to those after surgery to compare the cell growth. So far, more than 50 patients have participated. The preliminary results from this study are expected by the summer of 2004.
Advertisement
SUPPLEMENTS VS FOOD? Lycopene supplements are available on the market, but researchers say the supplements may not offer the same level of health protection. Experts point out that so far most studies have looked at intake of foods in the context of a whole diet. Therefore, including lycopene-rich foods is recommended over taking a supplement. LYCOPENE-RICH FOODS: The best way to include lycopene in your diet is to eat more processed tomato products. Research shows the body better absorbs lycopene when tomatoes are processed. While raw tomatoes have some lycopene, it takes more of them to make the processed foods, meaning there is more lycopene in each serving. Below is a list of foods and their lycopene content:
Lycopene Content in Foods (mg/100g)
Tomato Paste 42.2
Spaghetti Sauce 21.9
Chili Sauce 19.5
Tomato Ketchup 15.9
Tomato Juice 9.5
Pink Grapefruit 4.0
Raw Tomato 3.0

 

Armstrong Promotes Cancer Research

Associated Press

AUSTIN, Texas – With Lance Armstrong pushing for a record sixth consecutive Tour de France title this summer, his cancer research foundation is using the signature color of the world’s most grueling bicycle race for a new fund-raising campaign. The Lance Armstrong Foundation and Nike are promoting the sale of yellow wristbands engraved with the message, “Live Strong.”

“Yellow has taught me the true meaning of sacrifice. Yellow makes me suffer. Yellow is the reason I’m here,” Armstrong said. “Young people with cancer should be empowered to fight hard, dream big and live strong.”

The company will donate $1 million to the foundation, which hopes to raise an additional $5 million through wristband sales. Proceeds will go to the foundation for programs for young people with cancer. Foundation President Mitch Stoller said officials hope the wristbands will become as recognizable as the pink ribbons associated with breast cancer.

Armstrong overcame advanced testicular cancer that had spread to his lungs and brain. He went from having a 50 percent chance to live in 1996 to a string a five straight tour wins from 1999-2003, forever linking himself with the yellow jersey worn by the tour leader and champion.

 

Bush’s Trillion $ LIES About SS

WASHINGTON, Oct. 26 /PRNewswire/ — The Susan G. Komen Breast Cancer Foundation, credited as the nation’s leading catalyst in the fight against breast cancer, released today a non-partisan comparison of key health care proposals announced by Vice President Gore and Governor Bush in their quest for the Presidency.  The comparison is based on answers to a health care questionnaire designed by the Komen Foundation, to which both campaigns responded.  The Foundation hopes that the side-by-side analysis of the candidates’ varying proposals will assist voters in comparing and contrasting the approach each would take to important health care issues impacting women and families.

As a leader in the healthcare arena, the Susan G. Komen Breast Cancer Foundation has consistently promoted a broad range of issues impacting women and families.  The Komen Foundation, a bipartisan non-profit organization, works to educate women throughout the United States about the importance of these issues in their daily lives.

The Komen Foundation is an international organization with 114 domestic Affiliates in 45 states and the District of Columbia, as well as three Affiliates in Germany, Greece and Italy.  Since its inception, the Komen Foundation has raised more than $300 million to support breast cancer research, education, and screening and treatment programs.  These programs include cutting-edge basic, clinical and translational breast cancer research, and innovative outreach programs in local communities to assist the medically underserved.  The Susan G. Komen Breast Cancer Foundation is a nonpartisan charitable organization that does not endorse or oppose any candidate for public office

‘Green’ terrorists set back cancer research

What if the knowledge that scientists might have gained about the cancer-like tree disease referred to below could have led to a cure for human cancer?
As an environmentalist myself I know that the possibility that greater scientific knowledge of plants and their diseases may lead to breakthroughs in the treatment and even cures of many human and animal
diseases.

“This group is sick. They damaged a program that is for the good of everyone. We feel personally violated.” — Jud Isebrands, scientist at federal forestry research center near Rhinelander. Calling it “an attack against bio-engineering,” a group of radical environmentalists said it destroyed 500 research trees and spray-painted graffiti on vehicles at a federal forestry laboratory near Rhinelander, officials said Friday.

The Seattle-based North American Earth Liberation Front, an underground environmental activist organization, claimed responsibility for killing rare nursery stock worth $750,000 and vandalizing eight vehicles at a research station run by the U.S. Forestry Sciences Laboratory. Using saws and machetes to cut down the trees, and then trampling on them, the group short-circuited a 30-year project aimed at finding a cure for a cancer-like disease that attacks poplar trees, said Jud Isebrands, a scientist at the facility.

In the Thursday night attack, the group painted large green-and-black slogans on automobiles that warned: “ELF is watching the U.S. Forest Service.” The group also spread acid on windshields, Isebrands said. Damage to vehicles was estimated at $20,000, he said. The ELF, which has claimed responsibility for 13 attacks causing $31 million in damages over the last six years, opposes manipulating genetic matter in plants and animals, said Craig Rosebraugh, the group’s spokesman.

At least four separate anti-bio-engineering groups have carried out more than 30 attacks this year at facilities that included strawberry and sugar beet fields in California, cornfields in Maine and a grass field in Oregon. But researchers at the Rhinelander nursery had not used bio- engineering methods on any of the trees that were destroyed, said Isebrands, a member of a team working to find a cure for septoria canker, a disease that forms tumor-like swellings on poplar trees, causing millions of dollars in damage nationwide.

“This was not bio-technology,” Isebrands said. “All of our work was done using traditional plant-breeding techniques that have been around for years. We simply took a genetically superior tree and matched it with another tree. Then you just hope to get a better plant.” Besides poplars, the attackers destroyed young red oaks and other tree species.

“This group is sick,” Isebrands said. “They damaged a program that is for the good of everyone. We feel personally violated. We run this area like a public park. It’s open to everyone. We don’t want to put razor wire around here.” The attack set back the research project by 10 to 15 years, Isebrands said. About 10 members of the research team had been preparing stock that requires about 10 years for each generation to mature before scientists can move on to the next phase.

ELF has taken credit for six similar attacks this year, including a New Year’s Eve incident involving a suite of offices at the Michigan State University’s Agriculture Hall. “ELF is definitely stepping up its actions,” Rosebraugh said. Rosebraugh said he was not a member of the group, but he received information from members, who remained anonymous.

ELF members work in small cells, he said, and members do not know the identity of members in other cells. The Wisconsin attack probably identity of members in other cells. The Wisconsin attack probably was conducted by members from outside the state, he said. To avoid getting caught, members rarely conduct attacks in their home states, he said.

2000CRE1167C BREAST CANCER RESEARCH STAMP REAUTHORIZATION ACT OF 2000

Mr. LAZIO. Mr. Speaker, I rise to introduce the bill entitled the Breast Cancer Research Stamps Reauthorization Act of 2000.
Breast cancer is the most commonly diagnosed cancer among women in the United States. More than 2 million American women are currently living with the disease, 1 million of whom have yet to be diagnosed. This year alone, 182,800 women will be diagnosed with breast cancer. Over 40,000 of them will lose their battle with this killer.
Breast cancer has taken an awful toll on the people of my home state. New York has the second-highest breast cancer mortality rate in the country. Between 1980 and 1994, the incidence of breast cancer in New York increased nearly 18 percent. Enactment of this bill will go a long way toward helping our effort to increase funding for breast cancer research. Only through the help of continued cancer research have more and more people become cancer survivors in recent years.
Since the issuance of the Breast Cancer Research stamp in the summer of 1998, 164 million Breast Cancer Research stamps have been sold rising over $12 million for breast cancer research. The stamp provides a convenient avenue for participation in the battle against this horrible disease. Unfortunately, without congressional intervention, the stamp will expire on July 28, 2000. Valuable research funds, as well as a mechanism to heighten public awareness of this horrible disease, will be lost.
This bill, The Breast Cancer Research Stamp Reauthorization Act of 2000 would extend the sale of the Breast Cancer Research stamp for an additional two years. The stamp would continue to cost 40 cents and sell as a first class stamp. The additional funds that are raised will go directly to breast cancer research at the National Institutes of Health and the Department of Defense.
I am pleased to report that this reauthorization bill has tremendous support throughout the health community. Supporters of the Breast Cancer Stamp Reauthorization Act of 2000 include the American Cancer Society, the American Medical Association, the Y-Me National Breast Cancer Organization, Leadership America, the National Association of Women’s Health, the American Cancer League, the American College of Surgeons, Friends of Cancer Research, and many others.
A Breast Cancer Research Stamp remains just as necessary today as it was when this authority was signed into law two years ago. According to the American Association for Cancer Research, 8 million people are alive today as a result of cancer research. To say that every dollar we continue to raise will save lives, can only underscore the importance of this legislation.
I urge my colleagues to join me in enacting this important legislation.

 

Postdoctoral Position in Signal Transduction and Cancer

Immediately available in Department of Pathology, Yale University School of Medicine. The applicant must have strong background in molecular biology or immunology or cancer biology. The commitment to basic science research is required.  The applicants with the potential to obtain a fellowship from NIH or other foundations are prefered.

Project will involve studies of signal transduction from cytokine receptors to transcription factor STAT and their possible roles in cancer development.

Background and our Research Interest:

A variety of protein ligands (such as hormones and cytokines) induce activation of protein tyrosine kinases (PTK) and affect gene expression.   Our laboratory working on a recently established signaling pathway involving direct activation of cytoplasmic transcription factors by tyrosine kinases. A direct signaling model of signal transduction has been proposed (Fu, 1992). In this model, the transcription factors (termed STAT) are directly activated by a membrane receptor-associated tyrosine kinase(s) through their   SH2 (Src homology region 2) domains. These activated transcription factors then translocate to the nucleus to join a nuclear protein to form an active transcriptional complex, inducing expression of specific functional proteins.  Most recently, studies from our lab and other laboratories have also demonstrated that Interferons, EGF, PDGF, CSF-1, IL-2, IL-3, IL-4, IL-5, IL-6, and IL-10 etc., all use this direct pathway to control nuclear transcriptional events (reviewed in Darnell et al., 1994). A fundamental question in cancer research is whether and how these signaling pathways are involved abnormal cell growth and transformation of normal cells.  Our current research is aiming to expand our understanding of the signal transduction of cytokines, especially the functions of STAT to the field of cancer immunology which includes STAT function in  cancer development  and in the general cellular immune responses.

 

BREAST CANCER RESEARCH — Buy Postage Stamps!!

As you may be aware, the US Postal Service recently released its new “Fund the Cure” stamp to help fund breast cancer research. The stamp was designed by Ethel Kessler of Bethesda, Maryland.  It is important that we take a stand against this disease that kills and maims so many of our mothers, sisters, and friends.

Instead of the normal $.33 for a stamp, this one costs $.40.  The additional $.07 will go to breast cancer research.  A “normal” book costs $6.60.  This one is only $8.00. It takes a few minutes in line at the Post Office and means so much.  If all stamps are sold, it will raise an additional $16,000,000 for this vital research. Many of us know women and their families whose lives are turned upside-down by breast cancer.  It takes so little to do so much in this drive.

While I have no objection to the issuance of semi-postal stamps to fund breast cancer research, I think that is is a self-deception.  The cure, if that is the correct term, is most likely to come from fundamental biological research pursued by biologists that are not quite so goal oriented to meet their sponsors’ desires.

During Nixon’s presidency, a “war” on cancer was started.  More than 20 years later the biggest steps to fight cancer have come from mainline biological research into subjects like genetics, angiogenesis, drug action, etc.  While the money spent was not wasted, it was not used efficiently.  The goal oriented research tries to tackle problems for which the science is not available.  It does sound good, however, to the desperate suffering from the disease.  In a sense, the science for a cure is not here yet.

It should be obvious to this group that arthritis has not been cured although fundamental knowledge has greatly increased.  The result has been better treatments.  Realize however, that study of autoimmune disease and immunity in general, for example, is what will pay dividends for BOTH arthritis and breast cancer therapy.

We also see another useless war in action.  The war on drugs.  It too is a means to divert resources into the pockets of special interests while doing little to solve our nation’s drug problems. I just had to get on my soap box.  It irks me to see people following panaceas that will only prove to be a disappointment.  The main advantage, not to be underated, is that it makes people feel emotionally better.